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EDITORIAL
Congenital obstructive nephropathy: Is the fog lifting?
Renal obstruction is well recognized as causing renal
dysfunction and can be reliably repaired, so why is there
still a fuss about UPJ obstruction sufficient to prompt
many laboratories, particularly Dr. Chevalier’s, to in-
vest significant time and effort in trying to define this
common entity [1]? The crux of this issue involves the
many neonates with renal dilation, usually detected pre-
natally, who have no obvious clinical problems and seem
to grow and thrive. While we know that some might have
demonstrable deterioration of renal function over time,
we clearly do not know who these children may be. The
controversy regarding congenital obstructive uropathy
remains lively and shows no sign of being readily resolved
[2]. Two camps have emerged in the ongoing debate, the
“watchers” and the “fixers.” The “watcher” assumes that
the incidence of renal functional deterioration can be
accurately measured, promptly detected, and corrected
with specific intervention in these children [3, 4]. The
“fixer” feels that renal deterioration is slowly ongoing,
inaccurately measured, and by the time intervention is
undertaken, may be irreversible to some degree. These
different perspectives seem to follow some cultural and
institutional lines, but are often quite unpredictable. This
paper attempts to shed further light on this murky debate.
Broadly put, this paper helps us recognize the spectrum
of hydronephrosis and obstruction. The relationship be-
tween the degree of obstruction and its consequences is
not necessarily linear, and there may be a threshold of
impact below which the kidney can maintain a homeo-
static compensation without deterioration, albeit for an
indeterminate time. While we all recognize the presence
of that spectrum, the relationship to the impact of ob-
struction on the kidney is less well understood. It is also
clear that obstruction, which may not appear to be very
severe, can yet produce abnormal development and loss
of function in the developing kidney. Glomerular loss is
not a trivial issue and must be viewed as a high-risk occur-
rence with obstruction. This paper also identifies possible
potential mechanisms for renal functional loss. These ob-
servations offer potential for both diagnosis and therapy.
Is it appropriate to simply accept this paper as a reflec-
tion of the infant with asymptomatic UPJ obstruction?
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Several concerns should be considered in the interpre-
tation of this paper. The critical question is whether this
model is relevant. There have been many models of uri-
nary obstruction, and all have limitations. This model is
in an early neonate in whom nephronogenesis is ongo-
ing. The assumption is that this is not markedly different,
in terms of renal response, to the fetal kidney with pre-
sumably slowly progressive obstruction. Even when the
kidney is still developing nephrons, after birth it has be-
come active in the renal work of filtration and homeosta-
sis, which the fetal kidney does not need to do while the
placenta is healthy; therefore, its responses to obstruc-
tion may be distinct. This obstruction is rather abrupt in
contrast to naturally occurring obstruction. This obstruc-
tion stays fixed, which might be the human pattern, but is
not really known. It has been argued that the technique
of burying the ureter in the psoas [5] is a more realistic
method of obstruction in that it “grows” with the animal.
We do not know if this is the actual case in humans. This
model shows apparent progressive hydronephrosis, with
increasing apparent renal functional loss over time. This
is certainly logical and intuitive, but it is uncommon to see
increasing hydronephrosis in patients with severe unilat-
eral hydronephrosis. Progressive hydronephrosis may be
a very different entity in this animal and may explain
the observed results, but may not apply to many humans.
The observation of somatic growth impairment in the ob-
structed animals is also challenging to interpret, as this is
not an observed occurrence in human. The authors sug-
gest the possibility of subtle tubular dysfunction, leading,
perhaps, to acidosis, and indeed this might be the case, as-
suming the rodent is more sensitive to these changes than
the human. Tubular loss is indeed suggested in this experi-
ment, and has been identified in human studies as well [6].
This hypothesis raises the important question of whether
human unilateral obstruction can induce tubular dysfunc-
tion that is not readily measured using current clinical
studies, such as radionuclide renography. This may cause
dysfunction, which, while compensated for during child-
hood, may become a clinical problem with time. Broadly
viewed, the model is imperfect, but more perfect than
most others. It focuses on what is clinically relevant, which
is high-grade unilateral renal obstruction early in devel-
opment. Identification of a threshold effect of obstruc-
tion on function is a critically important concept that
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has direct clinical bearing, as well as suggesting patho-
physiologic mechanisms. The observation of progres-
sive functional loss, impaired growth, and development
should send a strong message of caution to anyone con-
sidering observational management in these patients,
although it cannot yet justify universal early surgical in-
tervention. Only if we can identify those kidneys at risk
of obstructive nephropathy will we be able to rationally
select those for intervention.
Identification of the specific mechanisms of congenital
obstructive nephropathy offers the potential to interro-
gate those mechanisms for more precise diagnosis and
prognosis. Further, manipulation of those mechanisms
may ultimately permit therapeutic interventions more
specific than simple surgery. Adjunctive therapy with
surgery might also be a possibility if the alterations in the
regulation of growth and development can be reversed.
What direction should future investigation of congen-
ital obstruction take? The true impact of putative mech-
anisms can only be confirmed by direct manipulation,
either inhibition of the mechanism, or specific induction
of the mechanistic pathway to produce the anticipated
functional or developmental outcomes. Inhibition may
be produced as simply as with surgical decompression,
and the putative pathophysiologic pathways should be
halted if they are of significant impact. Pharmacologic
or genetic inhibition of mechanisms can provide mech-
anistic insights, as well as therapeutic potential. Transla-
tion to clinical practice will likely involve identification
of biomarkers that predict functional and developmen-
tal alterations, either ongoing or potential [7]. The best
markers will be those which are directly related to the
pathophysiologically relevant mechanisms, and which are
not diluted by the contralateral kidney. In all likelihood,
these will be found in the urine, but serum markers should
be considered as well. It is possible that the contralateral
renal response may be an accurate biomarker of the con-
dition of the obstructed kidney; markers of accelerated
growth or compensatory mechanisms may prove to be
useful. As with so many conditions being managed to-
day, asymptomatic congenital obstruction can be easily
diagnosed, but determination of the patient at real risk re-
mains an obstinate challenge. Models of these processes
that permit identification of patterns and mechanisms of
effect, such as this mouse model, are the best tools for
eventually permitting rational management decisions re-
garding risk.
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